The autoimmune disease diagnostics market can be segmented based on applications such as systemic autoimmune disease diagnostics and localized autoimmune disease diagnostics.This research report analyzes this market on the basis of its market segments, major geographies, and current market trends.
Sourced through from: www.transparencymarketresearch.com
Autoimmune disease refers to a medical disorder characterized by inflammatory reactions caused by the overactive immune response of the body resulting in the actions against own cells and body tissues. There are more than 80 types of autoimmune diseases and are known to be more prevalent in women than men. According to the National Institute of Health (NIH), autoimmune diseases are ranked amongst the top ten causes of death in women in the U.S. Autoimmune disease diagnostics include the procedures that assist in identification of disease type and stage. Symptoms associated with autoimmune diseases include inflammation, fatigue, fever, joint pain, and rashes. Inflammation can further lead to redness, heat, pain, and swelling of the affected body part. The increasing prevalence of autoimmune diseases, growing public awareness and supportive government policies are the major factors driving the global autoimmune disease diagnostics market. Improved laboratory techniques and advancements in the healthcare sector is also expected to fuel the market growth. However, low prevalence of localized autoimmune diseases as compared to systemic diseases and increasing rate of diagnostic errors are restraining the growth of autoimmune disease diagnostics market.
Browse Full Report with TOC @ http://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html
The autoimmune disease diagnostics market can be segmented based on applications such as systemic autoimmune disease diagnostics and localized autoimmune disease diagnostics. Systemic autoimmune disease diagnostics can be further categorized into rheumatoid arthritis diagnostic, ankylosing spondylitis diagnostics, and systemic lupus erythematosus. The product market based on technologies currently used for autoimmune disease diagnostics include indirect immunofluorescence (IIF-ANA), enzyme-linked immunoabsorbent assay (ELISA), western blot technique, dot blot technique, line blot technique, multiplex immunoassays and others (agglutination, double immune diffusion, and counterimmunoelectrophoresis). The analysis of autoantibodies (autoimmune disease) by immunofluorescence remains the hallmark of diagnosis but is being replaced by enzyme immunoassays (ELISA) and multiplexed assays due to its high disease specificity and efficiency.
Geographically, North America dominates the global autoimmune disease diagnostics market, followed by Europe. High prevalence, well developed medical infrastructure, government initiatives and increasing investments on R&D in these regions are the major drivers responsible for the market growth. A boost is expected in the U.S. autoimmune market due to implementation of the Patient Protection and Affordable Care Act (PPACA). In Europe, autoimmune disease diagnostics market has shown significant growth due to high prevalence of autoimmune diseases. Developed countries of Europe have projected high prevalence rate compared to other regions of the autoimmune disease diagnostics. The prevalence pattern in Europe is similar to North America i.e. women are more prone to cause autoimmune disease than men. China and India are expected to be the fastest growing markets in the next five years. The rising population, increasing awareness regarding better health care facilities, and improving health care infrastructure are the major drivers of autoimmune disease diagnostic market. South American countries such as Brazil and Mexico are the regions that have significant potential for growth due to developing medical infrastructure, high disposable income and rising prevalence of autoimmune diseases.
Some of the major companies operating in autoimmune disease diagnostic market are Abbott Laboratories Ltd, Active Biotech, AstraZeneca plc, Amgen, Inc., Eli Lilly and Company, 4SC AG, Bristol-Myers Squibb Company, Pfizer, Inc., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., and Johnson & Johnson Ltd.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Read More Reports on Pharmaceutical Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Inquiry Before Buying: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5351
Latest Press Release Reports: http://www.transparencymarketresearch.com/press-releases.htm
Latest Articles Reports: http://www.transparencymarketresearch.com/articles.htm
Mr. Nachiket Ghumare
90 State Street,
Albany NY – 12207
See on – alina martin